Akso Health Group
4 hedge funds and large institutions have $271K invested in Akso Health Group in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
21% more capital invested
Capital invested by funds: $224K → $271K (+$46.9K)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.02% less ownership
Funds ownership: 0.04% → 0.03% (-0.02%)
20% less funds holding
Funds holding: 5 → 4 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$121 |
| 2 |
BlackRock
New York
|
+$64 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$13.4K |
| 2 |
RhumbLine Advisers
Boston,
Massachusetts
|
-$5.54K |
| 3 |
Renaissance Technologies
New York
|
-$2.76K |
AHG Hedge Fund Activity: Q3 2025 in Review
4 of the 7,629 institutional investors tracked by Wall St. Rank reported a position in Akso Health Group (AHG) for Q3 2025, worth a combined $271K — up 21% from $224K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of AHG and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $121. The largest seller was Two Sigma Securities, exiting entirely with an estimated $13.4K sold.
- 4 institutional investors held Akso Health Group (AHG) as of Q3 2025, down from 5 in Q2 2025.
- Funds reported $271K of Akso Health Group stock for Q3 2025, up 21% quarter-over-quarter.
- 1 fund opened new Akso Health Group positions in Q3 2025 and 2 closed out, a net change of -1 holder.
- The largest Akso Health Group buyer in Q3 2025 was UBS Group, an estimated $121 added.
- The largest Akso Health Group seller in Q3 2025 was Two Sigma Securities, an estimated $13.4K sold.
Based on aggregated 13F filings for Q3 2025.